Daniele Bellavia

2.2k citations
69 papers · 1.7k indexed · 1 hit paper · h-index 23

Daniele Bellavia

65 papers receiving 1.7k citations

Hit Papers

Interleukin 3- receptor targeted exosomes inhibit in vitr...20172026202020232017100200300

Peers

Daniele Bellavia
Comparison fields: 5 of 124
  • Molecular Biology 1.1k
  • Cancer Research 679
  • Biomedical Engineering 213
  • Oncology 211
  • Rheumatology 133
Replace Qi Guo with:
Qi Guo China
Lavinia Raimondi Italy
Baosheng Guo China
Hao Yin China
Xiaolong Xu China
Qingyu Wang China
Hyunsoo Kim South Korea
Donald R. Gerecke United States
Weihua Yu China
Fei Kang China
Daniele Bellavia relative to Qi Guo China Qi Guo's profile →
Citations per field
00.5×
Qi Guo · 1×
Citations per year

Countries citing papers authored by Daniele Bellavia

Since Specialization
Citations

This map shows the geographic impact of Daniele Bellavia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Bellavia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Bellavia more than expected).

Fields of papers citing papers by Daniele Bellavia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Bellavia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Bellavia. The network helps show where Daniele Bellavia may publish in the future.

Co-authorship network of co-authors of Daniele Bellavia

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Bellavia. A scholar is included among the top collaborators of Daniele Bellavia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Bellavia. Daniele Bellavia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 2
4 4
5 1
6 6
7 1
8 6
9 1
10 13
11 22
12 1
13 2
14 15
15 6
16 12
17 21
18 19
19 35
20 7

About Daniele Bellavia

Daniele Bellavia is a scholar working on Cancer Research, Orthopedics and Sports Medicine and Rheumatology, having authored 69 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Bone Metabolism and Diseases (8 papers) and RNA and protein synthesis mechanisms (7 papers). The work is most often cited by research in Cancer Research (679 citations), Molecular Biology (1.1k citations) and Orthopedics and Sports Medicine (130 citations). Daniele Bellavia has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Gianluca Giavaresi, Angela De Luca, Milena Fini, Viviana Costa, Lavinia Raimondi, Riccardo Alessandro, Valeria Carina, Fabio Caradonna, Mauro Manno and Samuele Raccosta. Their work appears in journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026